Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Bone Diseases

fluorodeoxyglucose f18 has been researched along with Bone Diseases in 42 studies

Research

Studies (42)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (2.38)18.2507
2000's15 (35.71)29.6817
2010's22 (52.38)24.3611
2020's4 (9.52)2.80

Authors

AuthorsStudies
Alaskar, AS; Alhejazi, AY; Aljohani, SA; Almuthri, SA; Alruwaili, A; Alsalman, MJ; Gmati, GE; Mendoza, MAC; Numani, SP; Ozair, NM; Saib, IH; Syed, GS; Vishwakarm, RK1
Chen, Y; Ding, H; Fu, S; Li, Y; Lin, S; Ren, P; Tang, S; Xu, Y; Ye, H; Zhang, Y1
M V, M; Manda, D; Shukla, V; Suresh, A1
Appelman-Dijkstra, NM; de Geus-Oei, LF; van der Bruggen, W; Vriens, D1
Zheng, K; Zhuang, H1
Adams, HJA; de Klerk, JMH; Dubois, SV; Heggelman, BGF; Kwee, TC; Nix, M1
Kai, K; Kimura, S; Kojima, K; Kusaba, K; Naito, S; Nishida, Y; Taba, M; Ureshino, H1
Javadi, MS; Rowe, SP; Solnes, LB; Tulbah, RI1
de Vries, R; Dullaart, RP; Kerstens, MN; Plukker, JT; Slart, RH1
Blake, GM; Compston, JE; Fogelman, I; Frost, ML; Goldsmith, D; Moore, AE; Siddique, M; Skingle, L1
Avril, NE; Kohan, A1
Ba, R; Hu, S; Jiang, Q; Shi, X; Wang, L; Wu, L; Xi, X; Yang, Z; Yu, X; Zhang, Y; Zhu, Y; Zhuang, Q1
Dong, MJ; Liu, NH; Weng, WW; Xu, Q; Yang, J; Zhang, J; Zhu, YJ1
Basu, S; Hansson, SH; Hess, S; Høilund-Carlsen, PF; Pedersen, KT1
Ayres, KL; Delbeke, D; Hodges, PK; Martin, WH; Price, R; Spottswood, SE; Wang, L1
Nguyen, TT; Parker, BJ; Yachoui, R1
de Jong, VM; Goslings, JC; Schep, NW; Termaat, MF; van Eck-Smit, BL; van Vliet, KE1
Artiko, V; Grozdic Milojevic, I; Odalovic, S; Saranovic, D; Sobic-Saranovic, D; Videnovic-Ivanov, J1
Ashamalla, M; Grimm, R; Hegener, P; Koutroumpakis, E; McCarthy, L; Mehdi, S1
Bailly, C; Bodet-Milin, C; Bourgeois, M; Carlier, T; Chérel, M; Guérard, F; Jamet, B; Kraeber-Bodéré, F; Leforestier, R; Moreau, P; Touzeau, C1
Liu, S; Numani, S; Yang, H1
Bal, C; Kansara, S; Khadgawat, R; Kotwal, P; Seith, A; Singh, Y; Tandon, N1
Jakobsen, AL; Jensen, M1
Kgomo, M; Maes, A; Pottel, H; Sathekge, M; Stoltz, A; Van de Wiele, C1
Dimopoulos, MA; Moulopoulos, LA; Terpos, E1
Bernit, E; Chagnaud, C; Ebbo, M; Harlé, JR; Mosnier, E; Schleinitz, N; Siles, P; Tintignac, A; Veit, V1
Chen, X; Wang, X; Yin, J1
Anthony, MP; Tsang, JS; Wong, CS; Wong, MP1
Delbeke, D; Fordice, S; Lamar, R; Ludwig, V; Martin, WH1
Aoki, J; Endo, K; Higuchi, T; Oriuchi, N; Tanada, S; Tian, M; Watanabe, H; Zhang, H1
Alavi, A; Kung, JW; Zhuang, H1
Aberg, C; Amorosi, E; Kramer, E; Moran, V; Ponzo, F; Raphael, B1
Hamada, K; Hatazawa, J; Higuchi, I; Inoue, A; Myoui, A; Tamai, N; Ueda, T; Yoshikawa, H1
Hashimoto, J; Joishi, D; Kubo, A; Nakahara, T; Suzuki, T; Tanaka, C; Uno, K1
Duet, M; Faraggi, M; Lioté, F; Pouchot, J1
Aratake, M; Inoue, T; Oka, T; Saitou, T; Takahashi, A; Takahashi, N; Tayama, Y1
Mulligan, ME; Smith, S; Talmi, D1
Dehdashti, F; Fusselman, MJ; Griffeth, LK; McGuire, AH; McGuire, DJ; Siegel, BA; Trask, DD1
Arens, S; Biersack, HJ; Grünwald, F; Hansis, M; Kälicke, T; Keller, E; Risse, JH; Schmitt, O; Schmitz, A1
Kato, K; Kobayashi, A; Oriuchi, N; Shinjyo, Y; Shinozaki, T; Takagishi, K; Watanabe, H1
Cook, GJ; Fogelman, I1
Bernd, L; Burger, C; Dimitrakopoulou-Strauss, A; Ewerbeck, V; Heichel, T; Strauss, LG; Wu, H1

Reviews

10 review(s) available for fluorodeoxyglucose f18 and Bone Diseases

ArticleYear
Benign Bone Conditions That May Be FDG-avid and Mimic Malignancy.
    Seminars in nuclear medicine, 2017, Volume: 47, Issue:4

    Topics: Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed

2017
Pelvis: normal variants and benign findings in FDG-PET/CT imaging.
    PET clinics, 2014, Volume: 9, Issue:2

    Topics: Bone Diseases; Colonic Diseases; Female; Fluorodeoxyglucose F18; Genital Diseases, Female; Genital Diseases, Male; Humans; Male; Multimodal Imaging; Pelvic Bones; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Urinary Bladder Diseases

2014
A systematic review of MRI, scintigraphy, FDG-PET and PET/CT for diagnosis of multiple myeloma related bone disease--which is best?
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:22

    Topics: Area Under Curve; Bone Diseases; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meta-Analysis as Topic; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed

2014
FDG-PET/CT in Infectious and Inflammatory Diseases.
    PET clinics, 2014, Volume: 9, Issue:4

    Topics: Arthritis, Rheumatoid; Bacterial Infections; Bone Diseases; Endocarditis; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Inflammation; Inflammatory Bowel Diseases; Multimodal Imaging; Positron-Emission Tomography; Psoriasis; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Vasculitis; Venous Thromboembolism

2014
Bone and bone marrow involvement in sarcoidosis.
    Rheumatology international, 2015, Volume: 35, Issue:11

    Topics: Adult; Biopsy; Bone Diseases; Bone Marrow; Bone Marrow Diseases; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Humerus; Hydroxychloroquine; Ilium; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Patella; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome; Whole Body Imaging

2015
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients.
    International journal of molecular sciences, 2017, Feb-18, Volume: 18, Issue:2

    Topics: Bone Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Treatment Outcome

2017
Advances in imaging and the management of myeloma bone disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, May-10, Volume: 29, Issue:14

    Topics: Bone Diseases; Diphosphonates; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Tomography, X-Ray Computed

2011
Implications of PET based molecular imaging on the current and future practice of medicine.
    Seminars in nuclear medicine, 2004, Volume: 34, Issue:1

    Topics: Animals; Bone Diseases; Cardiovascular Diseases; Central Nervous System; Fluorodeoxyglucose F18; Humans; Inflammation; Isotope Labeling; Neoplasms; Practice Patterns, Physicians'; Radiopharmaceuticals; Subtraction Technique; Tomography, Emission-Computed

2004
Role for positron emission tomography in skeletal diseases.
    Joint bone spine, 2007, Volume: 74, Issue:1

    Topics: Arthritis; Bone Diseases; Bone Diseases, Infectious; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Rheumatic Diseases; Sensitivity and Specificity; Vasculitis

2007
The role of positron emission tomography in skeletal disease.
    Seminars in nuclear medicine, 2001, Volume: 31, Issue:1

    Topics: Bone Diseases; Bone Neoplasms; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed

2001

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Bone Diseases

ArticleYear
Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases.
    European journal of nuclear medicine, 2000, Volume: 27, Issue:5

    Topics: Adult; Aged; Antitubercular Agents; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Infections; Male; Middle Aged; Osteomyelitis; Radiopharmaceuticals; Spondylitis; Tomography, Emission-Computed; Tuberculosis, Osteoarticular

2000

Other Studies

31 other study(ies) available for fluorodeoxyglucose f18 and Bone Diseases

ArticleYear
Radiological outcome of bone disease in multiple myeloma patients pre- and post therapy: A single center experience.
    Saudi medical journal, 2022, Volume: 43, Issue:8

    Topics: Bone Diseases; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies

2022
Predictive value of
    Frontiers in immunology, 2023, Volume: 14

    Topics: Bone Diseases; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Hydrolases; Lung Neoplasms; Metabolic Diseases; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Retrospective Studies

2023
Incidental FAPI Localization in Benign Bone Lesions in a Case of Carcinoma Stomach.
    Clinical nuclear medicine, 2023, Dec-01, Volume: 48, Issue:12

    Topics: Bone Diseases; Carcinoma; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Stomach Neoplasms

2023
Considerations on bone volume normalization in quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT.
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:6

    Topics: Bone Diseases; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Sodium Fluoride

2020
FDG PET/CT Findings of Nodular Sclerosis-Subtype Classic Hodgkin Lymphoma Presented as Mediastinal Nodal Lesions at Onset But as Predominant Osseous Disease at Relapse.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:6

    Topics: Bone Diseases; Chronic Disease; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Male; Mediastinum; Positron Emission Tomography Computed Tomography; Recurrence; Sclerosis; Young Adult

2017
Paraneoplastic Sarcoidosis in Multiple Myeloma.
    Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:15

    Topics: Aged; Biopsy; Bone Diseases; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Mediastinum; Multiple Myeloma; Paraneoplastic Syndromes; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed

2017
Nivolumab-Associated Pulmonary and Bone Sarcoidosis in a Patient With Melanoma of Unknown Primary.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:9

    Topics: Bone Diseases; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lymphadenopathy; Male; Melanoma; Middle Aged; Neoplasms, Unknown Primary; Nivolumab; Positron Emission Tomography Computed Tomography; Sarcoidosis

2019
Multiple skeletal lesions on FDG PET in severe primary hyperparathyroidism.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:1

    Topics: Bone Diseases; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Positron-Emission Tomography

2014
(18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease.
    Calcified tissue international, 2013, Volume: 93, Issue:5

    Topics: Adult; Aged; Bone Density; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteogenesis; Positron-Emission Tomography; Renal Dialysis; Renal Insufficiency, Chronic

2013
Disseminated sclerotic bone lesions with normal (18)F-fluorodeoxyglucose uptake in polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:7

    Topics: Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; POEMS Syndrome; Prognosis; Radiopharmaceuticals; Tissue Distribution

2015
Dose Optimization of the Administered Activity in Pediatric Bone Scintigraphy: Validation of the North American Consensus Guidelines.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:9

    Topics: Adolescent; Bone Diseases; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Guideline Adherence; Humans; Image Enhancement; Infant; Male; Medical Oncology; North America; Pediatrics; Positron-Emission Tomography; Practice Guidelines as Topic; Radiation Dosage; Radiation Protection; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tennessee

2015
Physiological uptake values of 18F-FDG in long bones of the lower extremity on PET/CT imaging.
    Nuclear medicine communications, 2016, Volume: 37, Issue:6

    Topics: Adult; Age Factors; Bone Diseases; Female; Femur; Fluorodeoxyglucose F18; Humans; Lower Extremity; Male; Middle Aged; Organ Specificity; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Tibia; Tissue Distribution

2016
FDG PET/CT in bone sarcoidosis.
    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2016, Mar-29, Volume: 33, Issue:1

    Topics: Adult; Aged; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Prospective Studies; Radiopharmaceuticals; Sarcoidosis

2016
Osseous Sarcoidosis Mimicking Metastatic Cancer on Positron Emission Tomography.
    Journal of oncology practice, 2016, Volume: 12, Issue:7

    Topics: Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma; Low Back Pain; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sodium Fluoride; Tomography, X-Ray Computed

2016
Monitoring the Therapy of Extensive Osseous Sarcoidosis With FDG PET/CT.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:7

    Topics: Biopsy; Bone Diseases; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sarcoidosis; Treatment Outcome

2017
PET/CT localisation of a scapular haemangiopericytoma with tumour-induced osteomalacia.
    Singapore medical journal, 2009, Volume: 50, Issue:2

    Topics: Adult; Bone Diseases; Contrast Media; Female; Fluorodeoxyglucose F18; Hemangiopericytoma; Humans; Magnetic Resonance Imaging; Osteomalacia; Paraneoplastic Syndromes; Positron-Emission Tomography; Radiopharmaceuticals; Scapula; Tomography, X-Ray Computed; Vitamin D

2009
[Picture of the month: bone scintigraphy].
    Ugeskrift for laeger, 2009, Jun-22, Volume: 171, Issue:26

    Topics: Bone and Bones; Bone Diseases; Drug Costs; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Technetium

2009
Impact of FDG PET on the management of TBC treatment. A pilot study.
    Nuklearmedizin. Nuclear medicine, 2010, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Infant; Joint Diseases; Lung; Lymph Nodes; Male; Middle Aged; Pilot Projects; Pleural Effusion; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis

2010
Clinical images: Bone sarcoidosis mimicking multiple metastases.
    Arthritis and rheumatism, 2011, Volume: 63, Issue:6

    Topics: Adult; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Low Back Pain; Magnetic Resonance Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Sarcoidosis; Technetium Tc 99m Pentetate; Tomography, X-Ray Computed

2011
Syphilitic bone destruction on FDG PET/CT.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:7

    Topics: Adult; Bone and Bones; Bone Diseases; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Syphilis; Tomography, X-Ray Computed

2011
The use of FDG-PET/CT in extranodal Rosai-Dorfman disease of bone.
    Skeletal radiology, 2012, Volume: 41, Issue:6

    Topics: Adult; Bone Diseases; Fluorodeoxyglucose F18; Histiocytosis, Sinus; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2012
Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:3

    Topics: Bone Diseases; Bone Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis; Sarcoidosis, Pulmonary; Tomography, Emission-Computed; Whole-Body Counting

2003
11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET.
    Nuclear medicine communications, 2003, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Diseases; Bone Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed

2003
FDG positron emission tomography of bone involvement in sarcoidosis.
    AJR. American journal of roentgenology, 2004, Volume: 182, Issue:4

    Topics: Adult; Bone Diseases; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed

2004
FDG-PET imaging for chronic expanding hematoma in pelvis with massive bone destruction.
    Skeletal radiology, 2005, Volume: 34, Issue:12

    Topics: Aged; Anticoagulants; Bone Diseases; Chronic Disease; Fluorodeoxyglucose F18; Hematoma; Humans; Ilium; Male; Positron-Emission Tomography; Radiopharmaceuticals; Warfarin

2005
18F-FDG positron emission tomographic imaging in Erdheim-Chester disease with skeletal and extra-skeletal involvement.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:5

    Topics: Bone Diseases; Erdheim-Chester Disease; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography

2006
Clinical evaluation of the effect of attenuation correction technique on 18F-fluoride PET images.
    Annals of nuclear medicine, 2007, Volume: 21, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Artifacts; Bone and Bones; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2007
Central skeletal sarcoidosis mimicking metastatic disease.
    Skeletal radiology, 2008, Volume: 37, Issue:8

    Topics: Biopsy; Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed; Tomography, X-Ray Computed

2008
Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose.
    Radiology, 1996, Volume: 200, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Diseases; Bone Neoplasms; Child; Child, Preschool; Contrast Media; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Tomography, Emission-Computed

1996
FDG PET in the clinical evaluation of sarcoidosis with bone lesions.
    Annals of nuclear medicine, 2000, Volume: 14, Issue:4

    Topics: Adult; Bone Diseases; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Radiography; Sarcoidosis; Tomography, Emission-Computed

2000
The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:4

    Topics: Bayes Theorem; Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed

2002